Outlook Therapeutics, Inc. (OTLK)

Last Year

20-Apr-23 -- 19-Apr-24

Time Period:
0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Other

Other

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
1
(1)
17
0
4
+1
0
+2
0
+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
29-Mar-24 10:39 AM
View: 		28-Mar-24
Purchase
$22.24K
Haddadin Yezan Munther
Director
Insider Trading Sentiment for Haddadin Yezan Munther at Outlook Therapeutics, Inc. (OTLK):Outlook Therapeutics, Inc. - OTLK59%
3.17K to 5.05K		0
0
---- Show TxnsShow Insider Trades
11-Mar-24 4:43 PM
View: 		07-Mar-24
Private Purchase
$26.24K
Evanson Jeff
Chief Commercial Officer
Insider Trading Sentiment for Evanson Jeff at Outlook Therapeutics, Inc. (OTLK):Outlook Therapeutics, Inc. - OTLK8%
745.98K to 808.46K		0
0
---- Show TxnsShow Insider Trades
20-Mar-24 5:20 PM
View: 		18-Mar-24
Grant
0
Sukhtian Ghiath M.
Director
10% Owner
Insider Trading Sentiment for Sukhtian Ghiath M. at Outlook Therapeutics, Inc. (OTLK):Outlook Therapeutics, Inc. - OTLK66%
3.5M to 5.81M		0
0
---- Show TxnsShow Insider Trades
17-Apr-24 8:21 PM
View: 		15-Apr-24
Purchase
0
Syntone Ventures LLC
10% Owner
Insider Trading Sentiment for Syntone Ventures LLC at Outlook Therapeutics, Inc. (OTLK):Outlook Therapeutics, Inc. - OTLK72%
991.15K to 1.71M		0
0
---- Show TxnsShow Insider Trades
21-Apr-23 9:05 PM
View: 		20-Apr-23
Sale
($590.20K)
Dagnon Terry
Chief Operations Officer
Insider Trading Sentiment for Dagnon Terry at Outlook Therapeutics, Inc. (OTLK):Outlook Therapeutics, Inc. - OTLK(44%)
1.17M to 653.06K		0
0
---- Show TxnsShow Insider Trades